Prev：DRAK2 aggravates nonalcoholic fatty liver disease progression through SRSF6-associated RNA alternative splicing(A25012-30.9)
Next：DRAM1 enhances the proliferation and metastasis of gastric cancer through the PI3K/AKT/mTOR signaling pathway and energy metabolism.(KTB1100-3.9)
